Has the COVID-19 Pandemic Led to a Switch in the Volatility of Biopharmaceutical Companies?
Biopharmaceutical companies are critical in developing vaccines, treatments, and diagnostics for COVID-19. Thus, understanding the contagion effects of their stock market can have important economic implications, especially in the context of global financial markets. Due to the COVID-19 pandemic, bi...
Main Authors: | Adriana AnaMaria Davidescu, Eduard Mihai Manta, Oana Mihaela Vacaru (Boita), Mihaela Gruiescu, Razvan Gabriel Hapau, Paul Laurentiu Baranga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Mathematics |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-7390/11/14/3116 |
Similar Items
-
Exploring the Contagion Effect from Developed to Emerging CEE Financial Markets
by: Adriana AnaMaria Davidescu, et al.
Published: (2023-01-01) -
Can Bank be a Cause of Contagion during the Global Financial Crisis?
by: Nadhem Selmi, et al.
Published: (2014-06-01) -
Contagion risk in Equity Markets during Financial Crises and COVID-19: A comparison of developed and emerging markets
by: Paul-Francois Muzindutsi, et al.
Published: (2022-12-01) -
Dynamic Conditional Correlation Analysis of Stock Market Contagion: Evidence from the 2007-2010 Financial Crises
by: Zouheir Mighri, et al.
Published: (2013-09-01) -
Cross-Market Correlations and Financial Contagion from Developed to Emerging Economies: A Case of COVID-19 Pandemic
by: Taufeeque Ahmad Siddiqui, et al.
Published: (2022-06-01)